Nova Leap Health (NLH) Corporate presentation summary

Financial performance

• TTM revenue was US$33.6M and adjusted EBITDA was US$2.60M, with a 7.7% adjusted EBITDA margin for the 12 months ended June 30, 2026.

• Q2 2026 revenue was US$9.39M, up 17.1% YoY; adjusted EBITDA rose 65.2% YoY to US$955K, a 10.2% margin.

• Q2 2026 operating income was US$755K; TTM operating income was US$1.73M.

Care platform and growth strategy

• Provides personal and dementia care, companionship, daily living support, care management and palliative care across Nova Scotia and U.S. regions including New England, the Southeast, South Central and Midwest.

• Revenue comes from hourly care services, funded by private pay, long-term care insurance and Veterans Affairs.

• Growth paths include organic growth, market density and new offices, service expansion, and acquisitions; Lexington, KY and Waltham, MA were recent office openings.

• Plans include expanding care management and palliative care, while evaluating private nursing as a future addition; these priorities are strategic direction, not financial guidance.

Acquisition platform

• 23 acquisitions have been completed since 2016; the model is to acquire established care businesses, integrate shared systems, generate cash and reinvest while managing debt.

• Parkwood was acquired May 1, 2026, for C$3.5M; unaudited FY2025 target results were approximately C$3.8M revenue and C$785K adjusted EBITDA, implying an illustrative ~4.5x multiple.

• Parkwood consideration was funded with C$2.2M from an acquisition facility, C$1.0M cash and a C$0.3M seller promissory note; the acquisition adds density in an existing Nova Scotia market.